TRPV4 and myeloid sarcoma: For example, if TRPV4 increased microglia phagocytosis in MS, as we observed in vitro, but also increased expression of pro-inflammatory cytokines, this would lead to increased myelin clearance, subsequently decreasing inflammation and promoting remyelination.